Blockbusters Going Off-patent: Opportunities for Generics Manufacturers in Europe

Published by	Frost & Sullivan
Published	June, 2007	Product code	53409
Content info	72 Pages
Price	US $ 6500 Web Access (Regional License) US $ 7000 Hard Copy & Web Access (Regional License)

Introduction
Related Reports

Blockbusters Going Off-patent: Opportunities for Generics Manufacturers in Europe published by Frost & Sullivan in June, 2007. This report consists of 72 Pages and the price starts from US $ 6500.

Introduction

Abstract

This Frost & Sullivan research service titled Blockbusters Going off Patent - Opportunities for Generics provides a detailed analysis of the European generics market in light of various opportunities created by the patent expiry of blockbuster drugs. It includes an overview on generics, market engineering measurements, country-wise trend analysis, revenue forecasts, strategic recommendations and decision support databases.

This analysis is available through our Pharmaceuticals and Biotechnology Growth Partnership Services program. With this program, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.

1 BLOCKBUSTERS GOING OFF-PATENT, EXECUTIVE SUMMARY

Executive Summary
- Executive Summary

2 BLOCKBUSTERS GOING OFF-PATENT, GLOSSARY OF TERMS

Important Terms
- Definitions

3 BLOCKBUSTERS GOING OFF-PATENT, EUROPEAN GENERICS MARKET

Introduction
- Understanding Generic Drugs
- Importance of Generics
- Market Overview
- Scope and Segmentation
- Market Opportunity Analysis
- Research Methodology

4 MARKET ENGINEERING RESEARCH FOR THE EUROPEAN GENERICS MARKET

Market Dynamics
- Market Engineering Measurements
- Industry Challenges
- Market Drivers
- Market Restraints
- Revenue Forecasts
- Trends by Segment
- Trends by Geographic Region
- Competitive Structure
- Market Share Analysis
- Market Consolidation Analysis